Fort Collins, CO – March 12, 2006 - RMC Biosciences, Inc. (RMC) announced today that it will offer Virtual High-Throughput Screening (vHTS) services to the biopharmaceutical industry for drug discovery and drug lead optimization. vHTS is a method of screening large, virtual libraries of drug-like compounds in a search for promising lead candidates. With vHTS methods, research scientists and medicinal chemists can rapidly explore chemical space at low cost. vHTS services improve the drug discovery process by allowing researchers to identify potential new drug compounds and find drug analogues for existing drugs and lead compounds. This promotes the selection of promising drug candidates for further experimental testing and lead optimization.
